ANGIEX
Dead / Cancelled — Cancelled — Section 8 (as of 19 Jan 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86948305
- Registration number
- 5237896
- Mark type
- Design + words
- Filed
- 22 Mar 2016
- Published for opposition
- 06 Sept 2016
- Registered
- 04 Jul 2017
- Attorney of record
- Keith Toms
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Development of pharmaceutical preparations, medicines, and diagnostics; Research in the field of drugs and diagnostic preparations for detecting, imaging and treating cancer; Conducting early evaluations in the field of new pharmaceuticals and diagnostics preparations
Owner
- Angiex, Inc., Cambridge, MA, US
- Angiex, Inc., Cambridge, MA, US
- Angiex, Inc., Cambridge, MA, US
Prosecution history
- 19 Jan 2024 — CANCELLED SEC. 8 (6-YR)
- 04 Jul 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Jul 2017 — REGISTERED-PRINCIPAL REGISTER
- 01 Jun 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 May 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 May 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 May 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 May 2017 — ASSIGNED TO LIE
- 09 May 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 May 2017 — SOU TEAS EXTENSION RECEIVED
- 24 Apr 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Apr 2017 — NON-FINAL ACTION E-MAILED
- 24 Apr 2017 — SU - NON-FINAL ACTION - WRITTEN
- 05 Apr 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Mar 2017 — USE AMENDMENT FILED